Modernizing the medical world
Innovative Medical Device production
We use the latest technology to design and produce portable medical devices for muscle, nerve, and brain diagnostics.
Myoguide™Injection Guidance System
Myoguide™ is a handheld needle EMG guided injection system. Myoguide™ enables clinicians to see and hear, as well as challenge, the injection sites, before any drug is injected.
Myoguide™ System UPGRADE!
Myoguide's integrated stimulator can now stimulate in both 1.0mA and 0.1mA steps over the full 0-20mA stimulation range; Myoguide has 50, 100, 200, or 500μs stimulation pulse width choices; and stimulation frequency choices of 1, 3, 5, 7, or 10 Hz;
Please contact us about our new upgrade program!
Designed for clinicians managing patients with pain and spasticity. Clinicians can document patient history, treatment, treatment plans, generate reports, as well as, add and track spasticity, capability, and pain index scores.
Clinicians can mark, as well as, attach details, where they inject using anatomical graphics. They can also review the complete patient injection history at any time, using displayed coloured markers.
Powerful "at a glance" insights into your patients' progress are available using the graphics based system. Myoguide DOC™ includes built-in graphics series defining a variety of spasticity syndromes. There is also the capability to build your own customized anatomical graphic series, for clinically defined protocols, pertinent to each office or department.
Intronix is always at the forefront of technologies and constantly researching and developing new products. The products we have in development cover a wide range of applications, expanding our scope and contributing to support diagnostics and treatment.
The industry is constantly changing as new information and technologies are introduced to the medical world. Stay up-to-date with Intronix to remain knowledgeable and competitive in the medical device field.
Become an exclusive member
Sign up today to gain access to exclusive downloads, resources, and news
TORONTO, May15, 2018 – Chronic pain is a common condition with significant physical, psychological, social, and economic impact. The Institute of Medicine estimates that >100 million Americans suffer from chronic pain. Conservative estimates suggest that well over US $500 billion per year is spent in the treatment of these pain conditions. This is associated with…Read More
Imagine for a moment the many different advances in technology that have helped progress the effectiveness of healthcare over the years. The advent of computers, of laser technology, of the internet and many, many others have all made a significant impact on the quality and performance of healthcare provision, helping healthcare professionals, improving treatment standards…Read More
Intronix Technologies will be there to help out with the hands-on workshops, and answer any questions about Myoguide injection guidance system, and introducing our new patient management software system “Myoguide DOC”! The American Association of Physical Medicine and Rehabilitation Annual Assembly is taking place Colorado Convention Center, in Denver, from October 11-15, 2017. Myoguide DOC…Read More
Intronix Technologies to Collaborate With Western University to Develop Augmented Reality Medical Simulation and Training for Neuromuscular Injection Procedures
TORONTO, Sept. 6, 2017 /PRNewswire/ — Innovative augmented reality technology aimed at enhancing the delivery of medical simulations, which will assist the treatment of millions of patients suffering from pain and spasticity, will be developed thanks to new strategic collaboration. Medical professionals are expected to continuously acquire new knowledge and skills while treating their patients.…Read More
Myoguide DOC is designed for clinicians managing patients with pain and spasticity. Clinicians can document patient history, treatment, treatment plans, generate reports, as well as, add and track spasticity, capability, and pain index scores. Myoguide DOC Patient Management Software for Pain and Spasticity Clinicians can mark, as well as, attach details, where they inject using anatomical graphics. They can also…Read More
Come have a look at the first glimpse of Myoguide DOC on our new website page: http://www.intronixtech.com/myoguide-doc-patient-management-software-for-pain-and-spasticity/ Pain And Spasticity Management At A GLANCE! Designed for clinicians managing patients with pain and spasticity. Clinicians can document patient history, treatment, treatment plans, generate reports, as well as, add and track spasticity, capability, and pain index scores. Clinicians can mark, as well…Read More
Intronix will be attending the American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM) meeting in Phoenix, Arizona, September 13-16, 2017. This year’s meeting will be held at the JW Marriott Phoenix Desert Ridge Resort & Spa. We are looking forward to the opportunity to showcase our new patient management software package “Myoguide DOC”. Myoguide DOC…Read More
Intronix has been officially invited to supply Myoguide units for three hands-on workshops at the American Association of Physical Medicine and Rehabilitation. The AAPM&R Annual Assembly is taking place Colorado Convention Center , in Denver, from October 11-15, 2017. We are very pleased and honoured to have the opportunity to continue to support the AAPM&R! This will…Read More
Patient Pain Management at a Glance Myoguide DOC: Saves Time, Increases Productivity, and Improves Communication TORONTO, April 11, 2017 – Intronix Technologies will be launching “Myoguide DOC”, a comprehensive software package designed to help clinicians who inject Botulinum Toxins, such as Botox®, Dysport® and Xeomin® to manage their patient’s spasticity and pain. Myoguide DOC…Read More
EMG-GUIDED NEEDLE SYSTEM PROMISES NEW ERA OF MORE ACCURATE INJECTIONS Toronto, Nov. 13 – Demand by an aging population grows world wide for injected neuromodulator drugs to control the disorders and pain associated with a wide range of chronic and other diseases. However, as recent Federal Drug Agency (FDA) reports in the United States have…Read More